MHRA Approves Nemolizumab for Eczema and Prurigo Nodularis ...Middle East

Medscape - News
MHRA Approves Nemolizumab for Eczema and Prurigo Nodularis
The MHRA has granted marketing authorisation to nemolizumab (Nemluvio) to treat prurigo nodularis in adults and atopic dermatitis in people aged 12 and over. Medscape News UK

Read More Details
Finally We wish PressBee provided you with enough information of ( MHRA Approves Nemolizumab for Eczema and Prurigo Nodularis )

Also on site :